Development of tachyphylaxis on statin treatment.
Miserez
A R
AR
Keller
U
U
Mirsaidi
R
R
D000069059:Atorvastatin; D006538:Heptanoic Acids / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*; D011758:Pyrroles / Q000009:adverse effects / Q000627:therapeutic use; D012107:Research Design; D019821:Simvastatin / Q000009:adverse effects* / Q000627:therapeutic use*; D013618:Tachyphylaxis
D006538:Heptanoic Acids; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011758:Pyrroles; D000069059:Atorvastatin; D019821:Simvastatin